We are live on ! Find out more
CYT

Cyteir Therapeutics, Inc. Common Stock
CYT

Delisted

CYT was delisted on the 15th of March, 2024.

Back to rankings

38 hedge funds and large institutions have $344M invested in Cyteir Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 6

36% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 14

15% more funds holding

Funds holding: 33 → 38 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less capital invested

Capital invested by funds: $353M → $344M (-$8.51M)

Holders
38
Holders Change
+5
Holders Change %
+15.15%
% of All Funds
0.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
19
Increased
11
Reduced
6
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$60.3M
2
BlackRock
BlackRock
New York
+$7.32M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$5.07M
4
ACP
Acuta Capital Partners
California
+$2.13M
5
RCM
RA Capital Management
Massachusetts
+$1.93M

Top Sellers

Rank Fund Capital Flow
1
ABG
Ally Bridge Group
New York
-$5.74M
2
SCM
Suvretta Capital Management
New York
-$3.75M
3
MIM
Monashee Investment Management
Massachusetts
-$3.1M
4
Millennium Management
Millennium Management
New York
-$2.96M
5
HM
HealthCor Management
New York
-$2.57M
Name Holding Trade Value Shares
Change 		Change in
Stake
NHAS
1
Novo Holdings A/S
Denmark
$84.9M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$75.2M +$60.3M +3,225,453 +304%
RCM
3
RA Capital Management
Massachusetts
$58.8M +$1.93M +103,389 +3%
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$31.9M -$217K -11,609 -0.6%
APM
5
Avidity Partners Management
Texas
$29.5M -$2.34M -124,953 -7%
BBA
6
Baker Bros. Advisors
New York
$14.3M – – –
CCM
7
CAAS Capital Management
New York
$10.2M +$1.49M +79,746 +16%
ACP
8
Acuta Capital Partners
California
$6.88M +$2.13M +114,197 +41%
BlackRock
9
BlackRock
New York
$6.87M +$7.32M +391,399 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$5.99M +$5.07M +271,251 +388%
ABG
11
Ally Bridge Group
New York
$5.61M -$5.74M -307,305 -49%
SI
12
Sofinnova Investments
California
$4.32M -$349K -18,679 -7%
SFM
13
Sphera Funds Management
Israel
$2.37M +$190K +10,145 +8%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$1.67M +$1.47M +78,599 +483%
State Street
15
State Street
Massachusetts
$1.61M +$1.72M +91,891 New
Northern Trust
16
Northern Trust
Illinois
$1.28M +$1.37M +73,183 New
Citadel Advisors
17
Citadel Advisors
Florida
$482K +$514K +27,510 New
Charles Schwab
18
Charles Schwab
California
$361K +$384K +20,569 New
Bank of New York Mellon
19
Bank of New York Mellon
New York
$275K +$293K +15,651 New
GCM
20
Ghisallo Capital Management
Massachusetts
$263K -$187K -10,000 -40%
ACM
21
ACT Capital Management
Pennsylvania
$263K +$279K +14,910 +16,567%
Bank of America
22
Bank of America
North Carolina
$216K +$230K +12,318 +123,180%
N
23
Nuveen
North Carolina
$193K +$205K +10,992 New
Deutsche Bank
24
Deutsche Bank
Germany
$84K +$89.9K +4,812 New
AIG
25
American International Group
New York
$80K +$85.5K +4,576 New
1
2 3

CYT Hedge Fund Activity: Q3 2021 in Review

38 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Cyteir Therapeutics, Inc. Common Stock (CYT) for Q3 2021, worth a combined $344M — down 2.4% from $353M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new CYT positions and 14 closed out — a net gain of 5 holders — while 11 added to existing stakes and 6 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $60.3M. The largest seller was Ally Bridge Group, cutting an estimated $5.74M.

  • 38 institutional investors held Cyteir Therapeutics, Inc. Common Stock (CYT) as of Q3 2021, up from 33 in Q2 2021.
  • Funds reported $344M of Cyteir Therapeutics, Inc. Common Stock stock for Q3 2021, down 2.4% quarter-over-quarter.
  • 19 funds opened new Cyteir Therapeutics, Inc. Common Stock positions in Q3 2021 and 14 closed out, a net change of +5 holders.
  • The largest Cyteir Therapeutics, Inc. Common Stock buyer in Q3 2021 was Fidelity Investments, an estimated $60.3M added.
  • The largest Cyteir Therapeutics, Inc. Common Stock seller in Q3 2021 was Ally Bridge Group, an estimated $5.74M sold.

Based on aggregated 13F filings for Q3 2021.